In conclusion, a novel tumor promotor PSMC2 was identified in ovarian cancer, which is upregulated in ovarian cancer, accelerating cell proliferation and colony formation, promoting cell migration, inhibiting cell apoptosis and predicting poor prognosis. The gene discussed is PSMC2; the disease is ovarian carcinoma.